ScoreWhy is TransMedics Group, Inc. ?
1
With a growth in Net Profit of 1436.87%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 12 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 177.98 MM
- PRE-TAX PROFIT(Q) At USD 23.03 MM has Grown at 442.54%
- NET PROFIT(Q) At USD 24.32 MM has Grown at 476.83%
2
With ROE of 22.53%, it has a fair valuation with a 12.85 Price to Book Value
- Over the past year, while the stock has generated a return of 91.89%, its profits have risen by 137.2% ; the PEG ratio of the company is 0.4
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating Performance
- The stock has generated a return of 91.89% in the last 1 year, much higher than market (S&P 500) returns of 20.12%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to TransMedics Group, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is TransMedics Group, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
TransMedics Group, Inc.
81.96%
-0.26
55.91%
S&P 500
18.81%
1.04
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
88.07%
EBIT Growth (5y)
39.53%
EBIT to Interest (avg)
-3.78
Debt to EBITDA (avg)
1.84
Net Debt to Equity (avg)
0.76
Sales to Capital Employed (avg)
0.49
Tax Ratio
2.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.06%
ROE (avg)
5.81%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
57
Industry P/E
Price to Book Value
12.85
EV to EBIT
54.86
EV to EBITDA
41.88
EV to Capital Employed
9.74
EV to Sales
7.91
PEG Ratio
0.43
Dividend Yield
NA
ROCE (Latest)
17.75%
ROE (Latest)
22.53%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend33What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 177.98 MM
PRE-TAX PROFIT(Q)
At USD 23.03 MM has Grown at 442.54%
NET PROFIT(Q)
At USD 24.32 MM has Grown at 476.83%
ROCE(HY)
Highest at 32.48%
INVENTORY TURNOVER RATIO(HY)
Highest at 4.66 times
RAW MATERIAL COST(Y)
Fallen by -5.27% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 14.97 %
DEBTORS TURNOVER RATIO(HY)
Highest at 6.63 times
NET SALES(Q)
At USD 143.82 MM has Grown at 32.24%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for TransMedics Group, Inc.
Pre-Tax Profit
At USD 23.03 MM has Grown at 442.54%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 24.32 MM has Grown at 476.83%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 177.98 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Highest at 4.66 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
At USD 143.82 MM has Grown at 32.24%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Debt-Equity Ratio
Lowest at 14.97 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 6.63 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -5.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 6.85 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
